{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:58:46Z","timestamp":1790099926001,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Korea Ministry of Education","doi-asserted-by":"publisher","award":["RS-2025-25397599"],"award-info":[{"award-number":["RS-2025-25397599"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2025-02215282"],"award-info":[{"award-number":["RS-2025-02215282"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2025-00516708"],"award-info":[{"award-number":["RS-2025-00516708"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2025-02303064"],"award-info":[{"award-number":["RS-2025-02303064"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2023-00255021"],"award-info":[{"award-number":["RS-2023-00255021"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jconrel.2026.114950","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:24:23Z","timestamp":1776871463000},"page":"114950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Inhalable nanohybrid of delpazolid enhances antimicrobial host defense against mycobacterial pulmonary infection"],"prefix":"10.1016","volume":"395","author":[{"given":"So-Yeol","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geumseo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Mo","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Woong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taejung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seokjin","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Ho","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmita","family":"Sapkota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Seon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaseong","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Lag","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Kyeong","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114950_bb0005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41577-024-01124-3","article-title":"How macrophage heterogeneity affects tuberculosis disease and therapy","volume":"25","author":"Russell","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0010","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41579-025-01201-x","article-title":"Mycobacterium tuberculosis biology, pathogenicity and interaction with the host","volume":"23","author":"Warner","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.107849","article-title":"Update on multidrug-resistant tuberculosis preventive therapy toward the global tuberculosis elimination","volume":"155","author":"Matteelli","year":"2025","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2026.114950_bb0020","series-title":"Global Tuberculosis Report 2024","author":"W.H. Organization","year":"2024"},{"key":"10.1016\/j.jconrel.2026.114950_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007083","article-title":"The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases","volume":"13","author":"Baldwin","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jconrel.2026.114950_bb0030","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0035","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.drudis.2018.04.001","article-title":"NTM drug discovery: status, gaps and the way forward","volume":"23","author":"Wu","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.114950_bb0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0033-1333568","article-title":"Ecology of nontuberculous mycobacteria\u2014where do human infections come from?","volume":"34","author":"Falkinham","year":"2013","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2026.114950_bb0045","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2018.33.e65","article-title":"Changing epidemiology of nontuberculous mycobacterial lung diseases in a tertiary referral hospital in Korea between 2001 and 2015","volume":"33","author":"Ko","year":"2018","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.jconrel.2026.114950_bb0050","doi-asserted-by":"crossref","DOI":"10.4110\/in.2021.21.e40","article-title":"Host-pathogen interactions operative during Mycobacteroides abscessus infection","volume":"21","author":"Park","year":"2021","journal-title":"Immune Netw."},{"key":"10.1016\/j.jconrel.2026.114950_bb0055","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1183\/09031936.00149212","article-title":"Nontuberculous mycobacteria network European trials, the geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study","volume":"42","author":"Hoefsloot","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2026.114950_bb0060","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12931-022-02299-w","article-title":"Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery","volume":"23","author":"van der Laan","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.jconrel.2026.114950_bb0065","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/809014","article-title":"General overview on nontuberculous mycobacteria, biofilms, and human infection","volume":"2015","author":"Faria","year":"2015","journal-title":"J. Pathog."},{"key":"10.1016\/j.jconrel.2026.114950_bb0070","doi-asserted-by":"crossref","first-page":"1394220","DOI":"10.3389\/fmicb.2024.1394220","article-title":"Treatment for non-tuberculous mycobacteria: challenges and prospects","volume":"15","author":"Conyers","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0075","article-title":"Regimens of less than six months for treating tuberculosis","volume":"1999","author":"Gelband","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2026.114950_bb0080","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/S1473-3099(21)00586-7","article-title":"Expert panel group for management recommendations in non-tuberculous mycobacterial pulmonary, consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases","volume":"22","author":"Lange","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2026.114950_bb0085","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1093\/cid\/ciae421","article-title":"Nontuberculous mycobacterial pulmonary disease: patients, principles, and prospects","volume":"79","author":"Nguyen","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2026.114950_bb0090","doi-asserted-by":"crossref","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2026.114950_bb0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.livres.2021.02.001","article-title":"Clinical perspectives of isoniazid-induced liver injury","volume":"5","author":"Lei","year":"2021","journal-title":"Liver Res."},{"key":"10.1016\/j.jconrel.2026.114950_bb0100","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40121-023-00761-w","article-title":"Incidence of and risk factors for acute kidney injury during antituberculosis treatment: a prospective cohort study and literature review","volume":"12","author":"Chang","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.jconrel.2026.114950_bb0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12951-022-01307-x","article-title":"A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases","volume":"20","author":"He","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0110","article-title":"Inhalable microparticles as drug delivery systems to the lungs in a dry powder formulations","volume":"10","author":"Knap","year":"2023","journal-title":"Regener. Biomater."},{"key":"10.1016\/j.jconrel.2026.114950_bb0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccm.2014.10.005","article-title":"Treatment of slowly growing mycobacteria","volume":"36","author":"Philley","year":"2015","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.jconrel.2026.114950_bb0120","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1038\/s41598-021-86342-8","article-title":"Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Qin","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.114950_bb0125","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1056\/NEJMoa2310307","article-title":"Inhaled amikacin to prevent ventilator-associated pneumonia","volume":"389","author":"Ehrmann","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114950_bb0130","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jconrel.2017.11.036","article-title":"Inhalable particulate drug delivery systems for lung cancer therapy: nanoparticles, microparticles, nanocomposites and nanoaggregates","volume":"269","author":"Abdelaziz","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114950_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40005-025-00729-7","article-title":"Current trends in inhaled pharmaceuticals: challenges and opportunities in respiratory infections treatment","volume":"55","author":"Shah","year":"2025","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2026.114950_bb0140","first-page":"65","article-title":"Breathing new life nanomedicines for pulmonary drug delivery: targeting approaches, experimental models, and regulatory aspects","volume":"14","author":"Gholap","year":"2025","journal-title":"Beni-Suef U. J. Basic"},{"key":"10.1016\/j.jconrel.2026.114950_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114204","article-title":"Nanotechnology-based approaches to tackle bacterial infections","volume":"387","author":"Savadi","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114950_bb0150","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114950_bb0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12941-023-00655-2","article-title":"Effectiveness and safety of regimens containing linezolid for treatment of Mycobacterium abscessus pulmonary disease","volume":"22","author":"Cheng","year":"2023","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.jconrel.2026.114950_bb0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijid.2021.06.055","article-title":"Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China","volume":"109","author":"Wen","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2026.114950_bb0165","doi-asserted-by":"crossref","first-page":"e02752","DOI":"10.1128\/AAC.02752-16","article-title":"Activity of LCB01-0371, a novel oxazolidinone, against Mycobacterium abscessus","volume":"61","author":"Kim","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2026.114950_bb0170","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/jac\/dky096","article-title":"Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation","volume":"73","author":"Millard","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2026.114950_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12941-016-0156-y","article-title":"Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis","volume":"15","author":"Agyeman","year":"2016","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.jconrel.2026.114950_bb0180","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01684-21","article-title":"Early bactericidal activity of delpazolid (LCB01-0371) in patients with pulmonary tuberculosis","volume":"66","author":"Kim","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2026.114950_bb0185","doi-asserted-by":"crossref","first-page":"e00165","DOI":"10.1128\/AAC.00165-18","article-title":"Comparison of in vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in China","volume":"62","author":"Zong","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2026.114950_bb0190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101149","article-title":"Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm","volume":"38","author":"Kim","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.114950_bb0200","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/713610448","article-title":"Antimicrobial properties of lysozyme in relation to foodborne vegetative bacteria","volume":"29","author":"Masschalck","year":"2003","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0205","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.colsurfb.2006.01.017","article-title":"Adsorption of lysozyme to phospholipid and meibomian lipid monolayer films","volume":"48","author":"Mudgil","year":"2006","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.jconrel.2026.114950_bb0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biomaterials.2015.02.010","article-title":"Chitosan-catechol: a polymer with long-lasting mucoadhesive properties","volume":"52","author":"Kim","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114950_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jciso.2023.100092","article-title":"Mucoadhesive cellulose nanocrystal-chitosan nanocomposite for the delivery of hydrophobic compounds","volume":"11","author":"Kim","year":"2023","journal-title":"JCIS Open"},{"key":"10.1016\/j.jconrel.2026.114950_bb0220","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2026.114950_bb0225","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jconrel.2011.10.006","article-title":"Modeling of diffusion controlled drug delivery","volume":"161","author":"Siepmann","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114950_bb0230","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114950_bb0235","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1021\/acs.jpcb.2c02193","article-title":"Correlation between C\u2550O stretching vibrational frequency and pKa shift of carboxylic acids","volume":"126","author":"Saito","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jconrel.2026.114950_bb0240","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1186\/1556-276X-9-565","article-title":"Lysozyme-coated silver nanoparticles for differentiating bacterial strains on the basis of antibacterial activity","volume":"9","author":"Ashraf","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.jconrel.2026.114950_bb0245","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.chom.2016.07.007","article-title":"Mycobacterial acid tolerance enables phagolysosomal survival and establishment of tuberculous infection in vivo","volume":"20","author":"Levitte","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jconrel.2026.114950_bb0250","doi-asserted-by":"crossref","first-page":"14166","DOI":"10.1074\/jbc.M114.628891","article-title":"Vacuolar ATPase in phagosome-lysosome fusion","volume":"290","author":"Kissing","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.114950_bb0255","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.carbpol.2015.01.002","article-title":"Controlled uptake and release of lysozyme from glycerol diglycidyl ether cross-linked oxidized starch microgel","volume":"121","author":"Zhao","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2026.114950_bb0260","doi-asserted-by":"crossref","first-page":"114173","DOI":"10.1016\/j.eurpolymj.2025.114173","article-title":"A review of pH-responsive chitosan-based hydrogels for drug delivery applications","volume":"237","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2025","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2026.114950_bb0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1574-6968.1994.tb07194.x","article-title":"Mycobacterial cell wall: structure and role in natural resistance to antibiotics","volume":"123","author":"Jarlier","year":"1994","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.jconrel.2026.114950_bb0270","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0065-2911(08)60016-8","article-title":"The envelope layers of mycobacteria with reference to their pathogenicity","volume":"39","author":"Daffe","year":"1998","journal-title":"Adv. Microb. Physiol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0275","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021113","article-title":"The mycobacterial cell wall\u2014peptidoglycan and arabinogalactan","volume":"5","author":"Alderwick","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jconrel.2026.114950_bb0280","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.bi.64.070195.000333","article-title":"The envelope of mycobacteria","volume":"64","author":"Brennan","year":"1995","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jconrel.2026.114950_bb0285","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2010.07.114","article-title":"Didodecyldimethylammonium bromide (DDAB) induces caspase-mediated apoptosis in human leukemia HL-60 cells","volume":"147","author":"Kusumoto","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114950_bb0290","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3390\/app10072211","article-title":"Development of delpazolid for the treatment of tuberculosis","volume":"10","author":"Cho","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.jconrel.2026.114950_bb0295","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s12276-020-00552-0","article-title":"MiR-144-3p is associated with pathological inflammation in patients infected with Mycobacteroides abscessus","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.114950_bb0300","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0305","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0310","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.mucimm.2025.10.003","article-title":"Neutrophil-chemoattractant CXCL5 increases lung barrier permeability in acute lung injury","volume":"18","author":"Berger","year":"2025","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0315","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","article-title":"The CXCL8\/IL-8 chemokine family and its receptors in inflammatory diseases","volume":"10","author":"Russo","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114831","article-title":"Aerosol pulmonary immune engineering","volume":"199","author":"Sudduth","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114950_bb0325","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0330","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.cell.2021.01.042","article-title":"Tissue-specific immunity for a changing world","volume":"184","author":"Weisberg","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114950_bb0335","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1146\/annurev-immunol-093019-010426","article-title":"The innate immune response to Mycobacterium tuberculosis infection","volume":"39","author":"Ravesloot-Chavez","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0340","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"O\u2019Garra","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0345","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/AAC.46.8.2723-2726.2002","article-title":"Hematologic effects of linezolid: summary of clinical experience","volume":"46","author":"Gerson","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2026.114950_bb0350","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114950_bb0355","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12950-023-00360-z","article-title":"Advances in the study of macrophage polarization in inflammatory immune skin diseases","volume":"20","author":"Xia","year":"2023","journal-title":"J. Inflamm. (Lond.)"},{"key":"10.1016\/j.jconrel.2026.114950_bb0360","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.3390\/cells11192953","article-title":"Macrophage-mediated inflammation in skin wound healing","volume":"11","author":"Hassanshahi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.114950_bb0365","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1189\/jlb.0809549","article-title":"When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system","volume":"87","author":"Silva","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2026.114950_bb0370","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijid.2016.03.006","article-title":"Update on pulmonary disease due to non-tuberculous mycobacteria","volume":"45","author":"Stout","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2026.114950_bb0375","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S1473-3099(25)00289-0","article-title":"Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial","volume":"25","author":"Minja","year":"2025","journal-title":"Lancet Infect. Dis."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:00:17Z","timestamp":1783051217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926003536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":75,"alternative-id":["S0168365926003536"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114950","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhalable nanohybrid of delpazolid enhances antimicrobial host defense against mycobacterial pulmonary infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114950"}}